Israeli - Kiingereza - Ministry of Health

cts ltd - tamsulosin hydrochloride - tablets prolonged release, film coated - tamsulosin hydrochloride 0.4 mg - tamsulosin - tamsulosin - lower urinary tract symptoms ( luts) associated with benign prostatic hyperplasia (bph).

Umoja wa Ulaya - Kiingereza - EMA (European Medicines Agency)

sandoz gmbh - somatropin - turner syndrome; prader-willi syndrome; dwarfism, pituitary - pituitary and hypothalamic hormones and analogues - infants, children and adolescentsgrowth disturbance due to insufficient secretion of growth hormone (gh).growth disturbance associated with turner syndrome.growth disturbance associated with chronic renal insufficiency.growth disturbance (current height standard-deviation score (sds) < -2.5 and parental adjusted sds < -1) in short children / adolescents born small for gestational age (sga), with a birth weight and / or length below -2 standard deviations (sds), who failed to show catch-up growth (height velocity (hv) sds < 0 during the last year) by four years of age or later.prader-willi syndrome (pws), for improvement of growth and body composition. the diagnosis of pws should be confirmed by appropriate genetic testing.adultsreplacement therapy in adults with pronounced growth hormone deficiency. patients with severe growth hormone deficiency in adulthood are defined as patients with known hypothalamic pituitary pathology and at least one known deficiency of a pituitary hormone not being prolactin. these patients should undergo a single dynamic test in order to diagnose or exclude a growth hormone deficiency. in patients with childhood-onset isolated gh deficiency (no evidence of hypothalamic-pituitary disease or cranial irradiation), two dynamic tests should be recommended, except for those having low insulin-like-growth-factor-i (igf-i) concentrations (sds < -2) who may be considered for one test. the cut-off point of the dynamic test should be strict.

Filipino - Kiingereza - FDA (Food And Drug Administration)

ophtho equip, inc.- mumbai, india mfd. by: omni lens pvt. ltd. - gujarat, india -

Marekani - Kiingereza - NLM (National Library of Medicine)

newton laboratories, inc. - wormwood (unii: f84709p2xv) (wormwood - unii:f84709p2xv), semecarpus anacardium juice (unii: y0f0bu8rdu) (semecarpus anacardium juice - unii:y0f0bu8rdu), silver nitrate (unii: 95it3w8jze) (silver cation - unii:57n7b0k90a), arsenic trioxide (unii: s7v92p67ho) (arsenic cation (3+) - unii:c96613f5av), atropa belladonna (unii: wqz3g9pf0h) (atropa belladonna - unii:wqz3g9pf0h), bryonia alba root (unii: t7j046yi2b) (bryonia alba root - unii:t7j046yi2b), oyster shell calcium carbonate, crude (unii: 2e32821g6 - wormwood 10 [hp_x] in 1 ml - insomnia  formulated for associated symptoms such as the inability to fall asleep as well as return to sleep after waking, frequent waking and restlessness. formulated for associated symptoms such as the inability to fall asleep as well as return to sleep after waking, frequent waking and restlessness.

Marekani - Kiingereza - NLM (National Library of Medicine)

newton laboratories, inc. - wormwood (unii: f84709p2xv) (wormwood - unii:f84709p2xv), anacardium occidentale fruit (unii: 4a10jr4e7e) (anacardium occidentale fruit - unii:4a10jr4e7e), silver nitrate (unii: 95it3w8jze) (silver cation - unii:57n7b0k90a), arsenic trioxide (unii: s7v92p67ho) (arsenic trioxide - unii:s7v92p67ho), atropa belladonna (unii: wqz3g9pf0h) (atropa belladonna - unii:wqz3g9pf0h), bryonia alba root (unii: t7j046yi2b) (bryonia alba root - unii:t7j046yi2b), oyster shell calcium carbonate, crude (unii: 2e32821g6i - wormwood 15 [hp_x] in 1 ml - insomnia   formulated for associated symptoms such as the inability to fall asleep as well as return to sleep after waking, frequent waking and restlessness.

Marekani - Kiingereza - NLM (National Library of Medicine)

newton laboratories, inc. - wormwood (unii: f84709p2xv) (wormwood - unii:f84709p2xv), semecarpus anacardium juice (unii: y0f0bu8rdu) (semecarpus anacardium juice - unii:y0f0bu8rdu), silver nitrate (unii: 95it3w8jze) (silver cation - unii:57n7b0k90a), arsenic trioxide (unii: s7v92p67ho) (arsenic cation (3+) - unii:c96613f5av), atropa belladonna (unii: wqz3g9pf0h) (atropa belladonna - unii:wqz3g9pf0h), bryonia alba root (unii: t7j046yi2b) (bryonia alba root - unii:t7j046yi2b), oyster shell calcium carbonate, crude (unii: 2e32821g6i) (oy - wormwood 15 [hp_x] in 1 g - insomnia   formulated for associated symptoms such as the inability to fall asleep as well as return to sleep after waking, frequent waking and restlessness.

Marekani - Kiingereza - NLM (National Library of Medicine)

newton laboratories, inc. - wormwood (unii: f84709p2xv) (wormwood - unii:f84709p2xv), semecarpus anacardium juice (unii: y0f0bu8rdu) (semecarpus anacardium juice - unii:y0f0bu8rdu), silver nitrate (unii: 95it3w8jze) (silver cation - unii:57n7b0k90a), arsenic trioxide (unii: s7v92p67ho) (arsenic cation (3+) - unii:c96613f5av), atropa belladonna (unii: wqz3g9pf0h) (atropa belladonna - unii:wqz3g9pf0h), bryonia alba root (unii: t7j046yi2b) (bryonia alba root - unii:t7j046yi2b), oyster shell calcium carbonate, crude (unii: 2e32821g6 - wormwood 10 [hp_x] in 1 g - insomnia  formulated for associated symptoms such as the inability to fall asleep as well as return to sleep after waking, frequent waking and restlessness. formulated for associated symptoms such as the inability to fall asleep as well as return to sleep after waking, frequent waking and restlessness.

Malesia - Kiingereza - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

omni one marketing sdn. bhd. - tomato powder (lycopersicon esculentum); helianthus annuus (sunflower); grape seed extract (vitis vinifera); fructus daucus carota -

Malesia - Kiingereza - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

omni aaa (m) sdn bhd - myrciaria dubia extract; lycopersicon esculentum; vitis vinefera extract; euterpe olaracea -

Israeli - Kiingereza - Ministry of Health

novartis israel ltd - somatropin recombinant - solution for injection - somatropin recombinant 10 mg / 1.5 ml - somatropin - children: short stature due to inadequate or failed secretion of pituitary growth hormone or turner`s syndrome. short stature in children with renal insufficiency. growth disturbance (height sds<2.5 and parenteral adjusted height sds < -1) in short children born sga (sga - small for gestational age i.e. born small in relation to the length of the fetus development) with a birth weight and/or length < 2 sd who failed to show catch up growth (hv sds < 0 during the last year) by 4 years of age or later. prader willi syndrome (pws) for improvement of growth and body composition. adults: for adults who have suffered from growth-hormone deficiency since childhood. for adults who have acquired growth hormone deficiency due to a pituitary pathology causing hypopituitarism.